ELIGLUSTAT vs ELRANATAMAB-BCMM: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ELIGLUSTAT vs ELRANATAMAB-BCMM: Safety Overview
| Metric | ELIGLUSTAT | ELRANATAMAB-BCMM |
|---|---|---|
| Total FAERS Reports | 1,368 | 570 |
| Deaths Reported | 18 | 120 |
| Death Rate | 1.3% | 21.1% |
| Hospitalizations | 173 | 168 |
| Average Patient Age | 48.6 yrs | 69.5 yrs |
| % Female Patients | 57.1% | 49.4% |
| FDA Approval Date | Aug 17, 2022 | N/A |
| Manufacturer | Genzyme Corporation | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | N/A |